Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 203
Filtrar
4.
Transpl Infect Dis ; 21(2): e13036, 2019 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-30548559

RESUMO

We present a case of a 15-year-old girl with an allogenic renal transplant secondary to chronic glomerulonephritis of unknown etiology who presented with treatment refractory molluscum contagiosum of the lower extremities and perineum. Treatment of mollusca with pulsed dye laser resulted in a clinically significant and sustained response. To our knowledge, this is the first report of a successful treatment of molluscum contagiosum with pulsed dye laser in the setting of a renal transplant.


Assuntos
Transplante de Rim/efeitos adversos , Lasers de Corante/uso terapêutico , Molusco Contagioso/terapia , Adolescente , Doença Crônica , Feminino , Glomerulonefrite/complicações , Humanos , Hospedeiro Imunocomprometido , Molusco Contagioso/diagnóstico , Pele/patologia , Pele/virologia , Transplante Homólogo/efeitos adversos , Resultado do Tratamento
5.
Actas dermo-sifiliogr. (Ed. impr.) ; 109(5): 408-415, jun. 2018. ilus, tab
Artigo em Espanhol | IBECS | ID: ibc-175535

RESUMO

El molusco contagioso es una de las infecciones virales más frecuente en los niños. Aunque se trata de una infección de curso benigno y generalmente autolimitada, el tratamiento puede resultar complicado en la edad pediátrica cuando las lesiones son muy numerosas, están en áreas visibles, o producen molestias. Existen diversos tratamientos disponibles, cuya selección depende del número y localización de las lesiones, de la experiencia del médico que las trata, y de las preferencias de los padres o cuidadores. Este artículo proporciona una actualización sobre las diferentes terapias contra los moluscos contagiosos particularmente enfocadas a los pacientes pediátricos


Molluscum contagiosum is one of the most common viral infections in childhood. It is a benign and usually self-limiting infection, but its treatment in children can be challenging, particularly when the patient presents multiple lesions or when lesions are symptomatic or highly visible. Several treatment options exist. Choice of treatment depends on the number and location of lesions, the prior experience of the treating physician, and the preferences of the child's parents or carers. This article provides an update on treatment options for molluscum contagiosum, with a particular focus on immunocompetent pediatric patients


Assuntos
Humanos , Criança , Molusco Contagioso/terapia , Infecções por Poxviridae/terapia , Crioterapia
7.
Actas Dermosifiliogr ; 109(5): 408-415, 2018 Jun.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-29576186

RESUMO

Molluscum contagiosum is one of the most common viral infections in childhood. It is a benign and usually self-limiting infection, but its treatment in children can be challenging, particularly when the patient presents multiple lesions or when lesions are symptomatic or highly visible. Several treatment options exist. Choice of treatment depends on the number and location of lesions, the prior experience of the treating physician, and the preferences of the child's parents or carers. This article provides an update on treatment options for molluscum contagiosum, with a particular focus on immunocompetent pediatric patients.


Assuntos
Molusco Contagioso/terapia , Criança , Humanos
9.
Rev. bras. med. fam. comunidade ; 12(39): 1-12, jan.-dez. 2017. ilus
Artigo em Português | LILACS, Coleciona SUS | ID: biblio-877106

RESUMO

Objetivo: Molusco contagioso é uma infecção cutânea, causada pelo Molluscipox vírus. Diante da inexistência de um tratamento específico, esta pesquisa tem como objetivo verificar, segundo a literatura recente, os melhores métodos de tratamento em crianças imunocompetentes. Métodos: Revisão sistemática de literatura realizada no PubMed, bem como no Lilacs, Scielo, Medline e demais bases de dados abrangidas na Biblioteca Virtual em Saúde (BVS), com publicações de 2010 a 2016. Para evitar viés, foram utilizadas recomendações do PRISMA. Critérios do Oxford Centre for Evidence-Based Medicine e do sistema GRADE foram usados para classificação do nível de evidência dos estudos. Resultados: Curetagem, laser pulsado de contraste, crioterapia, exérese cirúrgica, KOH 2,5%, 5% e 10%, ácido tricloroacétrico, combinação de ácido lático e ácido salicílico, tretinoína 0,05% apresentaram boa proporção de cura, facilidade de realização e tempo de resolução. Os métodos de injeção intralesional do antígeno da Cândida e da vacina MMR, dieta balanceada, óleo de Malaleuca alternifólia e Ingenol Mebutate 0,05% mostraram-se promissores. Entretanto, cantaridina e imiquimod 5% creme não foram recomendados. Conclusão: As evidências obtidas não permitem indicar um método preferencial. A escolha do método de tratamento deve ser individualizada. Recomenda-se realizar mais pesquisas voltadas para cultura do vírus.


Objective: Molluscum contagiosum is a skin infection caused by the Molluscipox virus. Given the absence of a specific treatment, this study aims to verify according to recent literature the best methods for molluscum contagiosum treatment in immunocompetent children. Methods: This study is a systematic review conducted in PubMed, as well as Lilacs, Scielo, Medline and other data bases from the Biblioteca Virtual em Saúde (BVS), including publications from 2010 to 2016. The bias is avoided by using PRISMA recommendations . Criteria of the Oxford Center for Evidence-Based Medicine and the GRADE system were used to rank the level of evidence of the studies. Results: Curettage, pulsed dye laser, cryotherapy, surgical abscission, KOH 2.5%, 5% and 10%, trichloroacetic acid, combination of lactic acid and salicylic acid and 0.05% tretinoin showed good performances regarding cure rate, ease of implementation and resolution time. Moreover, methods such intralesional injection of antigen Candida and the MMR vaccine, balanced diet, Malaleuca oil alternifolia and ingenol Mebutate 0.05% showed relevant results. However, the use of cantharidin and imiquimod 5% cream is not recommended. Conclusion: It is not possible to indicate the most eligible method based on the evidence found. Therefore, treatment should be individualized. Future researches about the virus culture are recommended.


Objetivo: El molusco contagioso es una infección de la piel causada por el virus Molluscipox. Dada la ausencia de un tratamiento específico, la presente investigación tiene como objetivo verificar, de acuerdo con la literatura reciente, los mejores métodos de tratamiento en niños inmunocompetentes. Métodos: Revisión sistemática de la literatura realizada en el Pubmed, así como en Lilacs, Scielo, Medline y otras bases de datos en la Biblioteca Virtual de Salud (BVS), con publicaciones de 2010 a 2016. Para evitar sesgos, se utilizaron las recomendaciones del PRISMA. Se utilizaron los criterios del Centro de Oxford para la Medicina Basada en la Evidencia y el sistema GRADE para clasificar el nivel de evidencia de los estudios. Resultados: Curetaje, láser pulsado de contraste, crioterapia, exéresis quirúrgica, KOH 2,5%, 5% y 10%, ácido tricloroacétrico, la combinación de ácido láctico y ácido salicílico, tretinoína 0,05% exhibieron buena tasa de curación, facilidad de realización y tiempo de resolución. Los métodos de inyección intralesional de antígenos de Cándida y la vacuna triple vírica, dieta equilibrada, aceite de alternifolia Malaleuca y ingenol mebutate 0,05% se muestran prometedores. Sin embargo, no se recomienda las cremas de cantaridina y imiquimod al 5%. Conclusión: Las evidencias obtenidas no han elegido un método preferido. La elección del método de tratamiento debe ser individualizada. Se recomienda la realización de más investigaciones relcionadas con el cultivo del virus.


Assuntos
Humanos , Molusco Contagioso/terapia , Resultado do Tratamento , Dermatopatias Virais , Viroses
10.
Pediatr Dermatol ; 34(5): 504-515, 2017 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-28884917

RESUMO

Molluscum contagiosum (MC) is an infectious dermatosis that commonly presents in children and immunocompromised individuals. Although lesions usually resolve spontaneously after several months, they can be symptomatic and cause psychosocial distress. We review the evidence underlying treatment methods available for MC lesions, including potassium hydroxide, salicylic acid, hydrogen peroxide, retinoids, cantharidin, cryotherapy, curettage, and pulsed dye laser to aid practicing dermatologists in therapy selection.


Assuntos
Molusco Contagioso/terapia , Cantaridina/uso terapêutico , Crioterapia/métodos , Curetagem/métodos , Humanos , Peróxido de Hidrogênio/uso terapêutico , Hidróxidos/uso terapêutico , Lasers de Corante/uso terapêutico , Compostos de Potássio/uso terapêutico , Retinoides/uso terapêutico , Ácido Salicílico/uso terapêutico
11.
Cochrane Database Syst Rev ; 5: CD004767, 2017 05 17.
Artigo em Inglês | MEDLINE | ID: mdl-28513067

RESUMO

BACKGROUND: Molluscum contagiosum is a common skin infection that is caused by a pox virus and occurs mainly in children. The infection usually resolves within months in people without immune deficiency, but treatment may be preferred for social and cosmetic reasons or to avoid spreading the infection. A clear evidence base supporting the various treatments is lacking.This is an update of a Cochrane Review first published in 2006, and updated previously in 2009. OBJECTIVES: To assess the effects of specific treatments and management strategies, including waiting for natural resolution, for cutaneous, non-genital molluscum contagiosum in people without immune deficiency. SEARCH METHODS: We updated our searches of the following databases to July 2016: the Cochrane Skin Group Specialised Register, CENTRAL, MEDLINE, Embase, and LILACS. We searched six trial registers and checked the reference lists of included studies and review articles for further references to relevant randomised controlled trials. We contacted pharmaceutical companies and experts in the field to identify further relevant randomised controlled trials. SELECTION CRITERIA: Randomised controlled trials of any treatment of molluscum contagiosum in people without immune deficiency. We excluded trials on sexually transmitted molluscum contagiosum and in people with immune deficiency (including those with HIV infection). DATA COLLECTION AND ANALYSIS: Two review authors independently selected studies, assessed methodological quality, and extracted data from selected studies. We obtained missing data from study authors where possible. MAIN RESULTS: We found 11 new studies for this update, resulting in 22 included studies with a total of 1650 participants. The studies examined the effects of topical (20 studies) and systemic interventions (2 studies).Among the new included studies were the full trial reports of three large unpublished studies, brought to our attention by an expert in the field. They all provided moderate-quality evidence for a lack of effect of 5% imiquimod compared to vehicle (placebo) on short-term clinical cure (4 studies, 850 participants, 12 weeks after start of treatment, risk ratio (RR) 1.33, 95% confidence interval (CI) 0.92 to 1.93), medium-term clinical cure (2 studies, 702 participants, 18 weeks after start of treatment, RR 0.88, 95% CI 0.67 to 1.14), and long-term clinical cure (2 studies, 702 participants, 28 weeks after start of treatment, RR 0.97, 95% CI 0.79 to 1.17). We found similar but more certain results for short-term improvement (4 studies, 850 participants, 12 weeks after start of treatment, RR 1.14, 95% CI 0.89 to 1.47; high-quality evidence). For the outcome 'any adverse effect', we found high-quality evidence for little or no difference between topical 5% imiquimod and vehicle (3 studies, 827 participants, RR 0.97, 95% CI 0.88 to 1.07), but application site reactions were more frequent in the groups treated with imiquimod (moderate-quality evidence): any application site reaction (3 studies, 827 participants, RR 1.41, 95% CI 1.13 to 1.77, the number needed to treat for an additional harmful outcome (NNTH) was 11); severe application site reaction (3 studies, 827 participants, RR 4.33, 95% CI 1.16 to 16.19, NNTH over 40).For the following 11 comparisons, there was limited evidence to show which treatment was superior in achieving short-term clinical cure (low-quality evidence): 5% imiquimod less effective than cryospray (1 study, 74 participants, RR 0.60, 95% CI 0.46 to 0.78) and 10% potassium hydroxide (2 studies, 67 participants, RR 0.65, 95% CI 0.46 to 0.93); 10% Australian lemon myrtle oil more effective than olive oil (1 study, 31 participants, RR 17.88, 95% CI 1.13 to 282.72); 10% benzoyl peroxide cream more effective than 0.05% tretinoin (1 study, 30 participants, RR 2.20, 95% CI 1.01 to 4.79); 5% sodium nitrite co-applied with 5% salicylic acid more effective than 5% salicylic acid alone (1 study, 30 participants, RR 3.50, 95% CI 1.23 to 9.92); and iodine plus tea tree oil more effective than tea tree oil (1 study, 37 participants, RR 0.20, 95% CI 0.07 to 0.57) or iodine alone (1 study, 37 participants, RR 0.07, 95% CI 0.01 to 0.50). Although there is some uncertainty, 10% potassium hydroxide appears to be more effective than saline (1 study, 20 participants, RR 3.50, 95% CI 0.95 to 12.90); homeopathic calcarea carbonica appears to be more effective than placebo (1 study, 20 participants, RR 5.57, 95% CI 0.93 to 33.54); 2.5% appears to be less effective than 5% solution of potassium hydroxide (1 study, 25 participants, RR 0.35, 95% CI 0.12 to 1.01); and 10% povidone iodine solution plus 50% salicylic acid plaster appears to be more effective than salicylic acid plaster alone (1 study, 30 participants, RR 1.43, 95% CI 0.95 to 2.16).We found no statistically significant differences for other comparisons (most of which addressed two different topical treatments). We found no randomised controlled trial evidence for expressing lesions or topical hydrogen peroxide.Study limitations included no blinding, many dropouts, and no intention-to-treat analysis. Except for the severe application site reactions of imiquimod, none of the evaluated treatments described above were associated with serious adverse effects (low-quality evidence). Among the most common adverse events were pain during application, erythema, and itching. Included studies of the following comparisons did not report adverse effects: calcarea carbonica versus placebo, 10% povidone iodine plus 50% salicylic acid plaster versus salicylic acid plaster, and 10% benzoyl peroxide versus 0.05% tretinoin.We were unable to judge the risk of bias in most studies due to insufficient information, especially regarding concealment of allocation and possible selective reporting. We considered five studies to be at low risk of bias. AUTHORS' CONCLUSIONS: No single intervention has been shown to be convincingly effective in the treatment of molluscum contagiosum. We found moderate-quality evidence that topical 5% imiquimod was no more effective than vehicle in terms of clinical cure, but led to more application site reactions, and high-quality evidence that there was no difference between the treatments in terms of short-term improvement. However, high-quality evidence showed a similar number of general side effects in both groups. As the evidence found did not favour any one treatment, the natural resolution of molluscum contagiosum remains a strong method for dealing with the condition.


Assuntos
Molusco Contagioso/terapia , Adjuvantes Imunológicos/uso terapêutico , Aminoquinolinas/uso terapêutico , Anti-Infecciosos Locais/uso terapêutico , Peróxido de Benzoíla/uso terapêutico , Cimetidina/uso terapêutico , Humanos , Hidróxidos/uso terapêutico , Imiquimode , Molusco Contagioso/tratamento farmacológico , Myrtus , Azeite de Oliva/uso terapêutico , Fitoterapia/métodos , Óleos Vegetais/uso terapêutico , Compostos de Potássio/uso terapêutico , Povidona-Iodo/uso terapêutico , Ensaios Clínicos Controlados Aleatórios como Assunto , Remissão Espontânea , Ácido Salicílico/uso terapêutico , Nitrito de Sódio/uso terapêutico
12.
Artigo em Inglês | MEDLINE | ID: mdl-28521677

RESUMO

BACKGROUND: Molluscum contagiosum is a viral cutaneous infection in childhood that occurs worldwide. Physicians should familiarize themselves with this common condition. OBJECTIVE: To review in depth the epidemiology, pathophysiology, clinical manifestations, complications and, in particular, treatment of molluscum contagiosum. METHODS: A PubMed search was completed in Clinical Queries using the key term "molluscum contagiosum". Patents were searched using the key term "molluscum contagiosum" from www.google.com/patents, http: //espacenet.com, and www.freepatentsonline.com. RESULTS: Molluscum contagiosum is caused by a poxvirus of the Molluscipox genus. Preschool and elementary school-aged children are more commonly affected. The virus is transmitted by close physical contact, autoinoculation, and fomites. Typically, molluscum contagiosum presents as asymptomatic, discrete, smooth, flesh-colored, dome-shaped papules with central umbilication from which a plug of cheesy material can be expressed. Some authors suggest watchful waiting of the lesions.Many authors suggest active treatment of lesions for cosmetic reasons or concerns of transmission and autoinoculation. Active treatments may be mechanical (e.g. cryotherapy, curettage, pulsed dye laser therapy), chemical (e.g. cantharidin, potassium hydroxide, podophyllotoxin, benzoyl peroxide, tretinoin, trichloroacetic acid, lactic acid, glycolic acid, salicylic acid), immune-modulating (e.g. imiquimod, interferon-alpha, cimetidine) and anti-viral (e.g. cidofovir). Recent patents related to the management of molluscum contagiosum are also retrieved and discussed. These patents comprise of topical compositions and herbal Chinese medicine with limited documentation of their efficacy. CONCLUSION: The choice of treatment method should depend on the physician's comfort level with the various treatment options, the patient's age, the number and severity of lesions, location of lesions, and the preference of the child/parents. In general, physical destruction of the lesion, in particular, cryotherapy with liquid nitrogen and chemical destruction with cantharidin are the methods of choice for the majority of patients.


Assuntos
Cantaridina/administração & dosagem , Crioterapia/métodos , Molusco Contagioso/terapia , Fatores Etários , Criança , Pré-Escolar , Humanos , Irritantes/administração & dosagem , Lasers de Corante/uso terapêutico , Molusco Contagioso/epidemiologia , Molusco Contagioso/fisiopatologia , Nitrogênio/administração & dosagem , Patentes como Assunto , Índice de Gravidade de Doença
13.
Pediatr Dermatol ; 34(4): e191-e195, 2017 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-28543922

RESUMO

Molluscum contagiosum (MC) is a common, self-limited skin infection caused by a double-stranded DNA virus of the family Poxviridae. Although the morphology of the disease is well described, MC presenting at unusual sites can exhibit atypical morphology, resulting in misdiagnosis. This observational, retrospective case series discusses the novel morphology of MC presenting in the intergluteal cleft of five children seen in the outpatient dermatology clinic of an academic medical center. We present this case series to highlight this novel presentation of MC in children and to emphasize a conservative approach to management given the sensitive location and the self-limited nature of the infection.


Assuntos
Molusco Contagioso/diagnóstico , Instituições de Assistência Ambulatorial , Criança , Pré-Escolar , Diagnóstico Diferencial , Feminino , Humanos , Lactente , Masculino , Molusco Contagioso/terapia , Estudos Retrospectivos , Pele/patologia
16.
Pediatr Dermatol ; 33(6): 640-645, 2016 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-27601304

RESUMO

BACKGROUND/OBJECTIVES: Molluscum contagiosum (MC) is a common viral disease primarily affecting children. The objective was to compare the effectiveness of curettage as a treatment modality for MC with no treatment. METHODS: We performed a retrospective study of 2,022 children with MC between 2008 and 2012. Epidemiologic, clinical, and treatment data, including effectiveness, safety, and satisfaction, were reviewed. RESULTS: Fifty-six percent of the children were 2 to 5 years of age. The duration of the infection was 1 to 2 years for 51%, less than 1 year for 32%, and more than 2 years for 17% of the children. Seventy percent of the children were self-referrals; 86% had had a previous examination and 76% of those had been advised not to treat the infection. The disease was mild (22%), moderate (64%), or severe (14%). A total of 1,879 patients underwent curettage; 70% were cured after one treatment and 26% after two treatments. Satisfaction was high: 97% of children and parents. CONCLUSION: Active treatment should be offered despite the fact that MC is self-limiting. Curettage in an appropriate setting is very effective, with high patient satisfaction and fast cure rates.


Assuntos
Curetagem , Molusco Contagioso/terapia , Pré-Escolar , Feminino , Humanos , Masculino , Satisfação do Paciente , Estudos Retrospectivos , Resultado do Tratamento
17.
Pediatr Dermatol ; 33(5): e284-5, 2016 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-27397059

RESUMO

A eutectic mixture of lidocaine and prilocaine (EMLA) is used topically to provide local anesthesia for a variety of painful superficial procedures. Although the side effects of EMLA are usually mild and transient local reactions, potentially life-threatening complications can occur. We report a case of generalized seizures and methemoglobinemia after topical application of EMLA for curettage of molluscum contagiosum lesions in a 3.5-year-old girl with atopic dermatitis.


Assuntos
Anestésicos Locais/efeitos adversos , Dermatite Atópica/terapia , Lidocaína/efeitos adversos , Metemoglobinemia/induzido quimicamente , Molusco Contagioso/terapia , Prilocaína/efeitos adversos , Convulsões/induzido quimicamente , Administração Tópica , Pré-Escolar , Dermatite Atópica/complicações , Feminino , Humanos , Combinação Lidocaína e Prilocaína , Molusco Contagioso/complicações
18.
Curr Opin Pediatr ; 28(4): 490-9, 2016 08.
Artigo em Inglês | MEDLINE | ID: mdl-27269886

RESUMO

PURPOSE OF REVIEW: Warts and molluscum contagiosum are very common viral skin infections, usually presenting in childhood. Despite the large number of people affected by them, high-quality trials of treatment are few and treatment is often chosen on the basis of cost, convenience and tradition. RECENT FINDINGS: Over recent years, two further trials of the most commonly used treatments for warts, salicylic acid and cryotherapy, have been performed and for molluscum contagiosum, there is growing evidence for the use of irritants. For both infections, there are new evaluations of immunological approaches to therapy. SUMMARY: Strong, high-quality evidence for treatments used very frequently for warts or molluscum is still lacking, but recent publications have helped to strengthen or weaken belief in commonly used therapies and to add weight to the immunological approach to management.


Assuntos
Crioterapia , Imunoterapia , Lasers de Corante/uso terapêutico , Molusco Contagioso/terapia , Ácido Salicílico/uso terapêutico , Verrugas/terapia , Análise Custo-Benefício , Crioterapia/tendências , Medicina Baseada em Evidências , Humanos , Imunoterapia/tendências , Resultado do Tratamento
19.
Pediatr Dermatol ; 33(3): e214-5, 2016 May.
Artigo em Inglês | MEDLINE | ID: mdl-27041686

RESUMO

The tolerability of a 2.5% lidocaine/prilocaine hydrogel (Nanorap, Biolab Indústria Farmacêutica Ltd., Sao Paulo, Brazil) was evaluated in 20 children ages 2 to 11 years undergoing cryotherapy for molluscum contagiosum (MC). The product was well tolerated, with only two children presenting with eczema at the application site. These adverse reactions were considered unlikely to be related to the test product, because a patch test was negative in one of the individuals and the other event occurred in only one of the two treated areas. Nanorap is an efficacious and well-tolerated option for topical anesthesia in children undergoing cryotherapy for MC.


Assuntos
Anestésicos Locais/uso terapêutico , Crioterapia/efeitos adversos , Tolerância a Medicamentos , Molusco Contagioso/diagnóstico , Molusco Contagioso/terapia , Dor/prevenção & controle , Criança , Pré-Escolar , Crioterapia/métodos , Combinação de Medicamentos , Feminino , Humanos , Hidrogel de Polietilenoglicol-Dimetacrilato , Lidocaína/uso terapêutico , Masculino , Dor/etiologia , Medição da Dor , Prilocaína/uso terapêutico , Resultado do Tratamento
20.
J Ayub Med Coll Abbottabad ; 28(2): 382-385, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-28718569

RESUMO

Background:: Different topical therapies are being used for treating molluscum contagiosum. Potassium hydroxide in varying solution strengths with irritant reaction on the skin can help in eliminating the infection. It is cheap, easily available, can be easily applied at home, with good safety profile and cost effectiveness. This study was conducted to compare the efficacy of 10% potassium hydroxide solution versus cryotherapy in treating molluscum contagiosum. Methodology: This study was a Randomized control trial conducted in the Department of dermatology, Military hospital Rawalpindi. Study included 120 randomly selected patients with molluscum contagiosum divided equally into two groups. Group A were treated with 10% potassium hydroxide aqueous solution applied daily to the lesions twice daily for 6 weeks while Group B received weekly cryotherapy with liquid nitrogen. The status of lesions was documented weekly for 6 weeks. RESULTS: Of the 120 patients enrolled, 67 (55.8%) were male and 53 (44.2%) were female. Mean age of patients was 20.53(±8.17) years. At base line Molluscum contagiosum lesion ranged from minimum of 2 lesions to maximum of 26 lesions with a mean of 8.95 (SD ±4.45) lesions. Of 120 patients, complete clearance was observed in 98(81.6%) of patients, 48(80%) patients had lesion clearance in Group A and 50 (83.3%) patients had lesion clearance was observed in Group B. No statistical significance was observed in the lesion clearance between the two groups (p-0.63). CONCLUSIONS: The efficacy of 10% potassium hydroxide solution and cryotherapy is statistically same over 6 weeks of treatment. Thus less expensive, easily available and cosmetically more acceptable potassium hydroxide solution can be used instead of cryotherapy in treating molluscum contagiosum.


Assuntos
Crioterapia , Hidróxidos/uso terapêutico , Molusco Contagioso/terapia , Compostos de Potássio/uso terapêutico , Adolescente , Adulto , Criança , Feminino , Humanos , Masculino , Paquistão , Resultado do Tratamento , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA